In vitro activities of quinupristin-dalfopristin and the streptogramin RPR 106972 against Mycoplasma pneumoniae

Koichi Izumikawa, Yoichi Hirakata, Toshiyuki Yamaguchi, Ryoji Yoshida, Hironori Tanaka, Hiromu Takemura, Shigefumi Maesaki, Kazunori Tomono, Mitsuo Kaku, Kin Ichi Izumikawa, Shimeru Kamihira, Shigeru Kohno

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Abstract

The in vitro activities of quinupristin-dalfopristin and streptogramin RPR 106972 were determined with 44 strains of Mycoplasma pneumoniae and compared to those of macrolides, minocycline, and quinolones. All isolates tested were highly susceptible to macrolides and to quinupristin-dalfopristin (MIC at which 90% of the isolates are inhibited [MIC90], 0.0625 μg/ml), followed by RPR 106972 (MIC90, 0.5 μg/ml), quinolones, and minocycline.

Original languageEnglish
Pages (from-to)698-699
Number of pages2
JournalAntimicrobial agents and chemotherapy
Volume42
Issue number3
DOIs
Publication statusPublished - 1998 Mar

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'In vitro activities of quinupristin-dalfopristin and the streptogramin RPR 106972 against Mycoplasma pneumoniae'. Together they form a unique fingerprint.

Cite this